Vir Biotechnology Inc. (NASDAQ: VIR) stock fell -1.93% on Monday to $9.63 against a previous-day closing price of $9.82. With 1.35 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.51 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $9.79 whereas the lowest price it dropped to was $9.47. The 52-week range on VIR shows that it touched its highest point at $31.55 and its lowest point at $9.73 during that stretch. It currently has a 1-year price target of $32.75. Beta for the stock currently stands at 0.20.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VIR was down-trending over the past week, with a drop of -10.25%, but this was down by -24.23% over a month. Three-month performance dropped to -61.83% while six-month performance fell -59.32%. The stock lost -52.58% in the past year, while it has lost -61.95% so far this year. A look at the trailing 12-month EPS for VIR yields -1.97 with Next year EPS estimates of -4.31. For the next quarter, that number is -1.21. This implies an EPS growth rate of -3.40% for this year and 10.20% for next year. EPS is expected to grow by 7.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 92.00%.
Float and Shares Shorts:
At present, 134.06 million VIR shares are outstanding with a float of 113.19 million shares on hand for trading. On Aug 30, 2023, short shares totaled 4.57 million, which was 3.41% higher than short shares on Jul 30, 2023. In addition to Ms. Johanna Friedl-Naderer as the firm’s Exec. VP & COO, Dr. Ann M. Hanly Ph.D. serves as its Exec. VP & Chief Technology Officer.
Through their ownership of 75.95% of VIR’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 31.88% of VIR, in contrast to 29.76% held by mutual funds. Shares owned by individuals account for 23.43%. As the largest shareholder in VIR with 9.34% of the stake, BlackRock Fund Advisors holds 12,533,053 shares worth 12,533,053. A second-largest stockholder of VIR, The Vanguard Group, Inc., holds 10,094,670 shares, controlling over 7.52% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in VIR, holding 5,418,804 shares or 4.04% stake. With a 4.01% stake in VIR, the iShares Core S&P Small Cap ETF is the largest stakeholder. A total of 5,380,065 shares are owned by the mutual fund manager. The Scottish Mortgage Investment Trus, which owns about 2.83% of VIR stock, is the second-largest Mutual Fund holder. It holds 3,801,908 shares valued at 48.13 million. Vanguard Total Stock Market ETF holds 2.32% of the stake in VIR, owning 3,112,539 shares worth 39.4 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, VIR reported revenue of -$42.69M and operating income of -$225.22M. The EBITDA in the recently reported quarter was -$212.24M and diluted EPS was -$0.58.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VIR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With VIR analysts setting a high price target of $95.00 and a low target of $14.00, the average target price over the next 12 months is $32.75. Based on these targets, VIR could surge 886.5% to reach the target high and rise by 45.38% to reach the target low. Reaching the average price target will result in a growth of 240.08% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded VIR stock several times over the past three months with 0 Buys and 5 Sells. In these transactions, 0 shares were bought while 125,554 shares were sold. The number of buy transactions has increased to 25 while that of sell transactions has risen to 150 over the past year. The total number of shares bought during that period was 1,137,593 while 5,820,006 shares were sold.